In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
The Canadian Journal of Statistics / La Revue Canadienne de Statistique, Vol. 46, No. 3 (September/septembre 2018), pp. 399-415 (17 pages) For sparse and high-dimensional data analysis, a valid ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
The FDA has released new draft guidance outlining the use of Bayesian methodologies in clinical trials for drugs and biologics. The guidance is intended to help sponsors apply modern statistical ...
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...
Benefit of adding Cureety remote patient monitoring (RPM) to usual care during injectable anticancer treatment: The OPTIMACURE multicentric French prospective randomized study. This is an ASCO Meeting ...
Pantelis Samartsidis, Claudia R. Eickhoff, Simon B. Eickhoff, Tor D. Wager, Lisa Feldman Barrett, Shir Atzil, Timothy D. Johnson, Thomas E. Nichols Journal of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results